IKT Cash & Equivalents
Inhibikase Therapeutics Inc · Cash & Equivalents
IKT Cash & Equivalents
Latest reported$139.22Mperiod ending
IKT FY Cash & Equivalents ($12.04K → $139.22M)
Annual Cash & Equivalents
High-resolution chart · PNG
IKT cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 139,220,208 | |
| 56,490,579 | |
| 9,165,179 | |
| 7,188,553 | |
| 40,750,133 | |
| 13,953,513 | |
| 18,457 | |
| 379,557 | |
| 16,665 | |
| 12,036 |